TCON - TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5 2024 | Benzinga
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (NASDAQ:TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other life science companies, announced today that it will report its fourth quarter and year-end 2023 financial and operating results after the close of U.S. financial markets on Tuesday, March 5, 2024. In addition, management will host a conference call to provide an update on corporate activities and discuss the financial results.
| Date: |
| March 5, 2024 |
| Time: |
| 4:30 pm Eastern Time (1:30 pm Pacific Time) |
| Conference Call: |
| In order to ... |